Cerus Endovascular Announces IDE Approval from the U.S. FDA to Conduct Clinical Study of the Contour Neurovascular System(TM)

Patient Enrollment to Begin Within Three Months FREMONT, Calif. and OXFORD, United Kingdom, April 21, 2021 -- (Healthcare Sales & Marketing Network) -- Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, today announced ... Devices, Interventional, Neurosurgery, Regulatory Cerus Endovascular, Contour Neurovascular System, intracranial aneurysm
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news